BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15049841)

  • 1. Biological activity of silylated amino acid containing substance P analogues.
    Cavelier F; Marchand D; Martinez J; Sagan S
    J Pept Res; 2004 Mar; 63(3):290-6. PubMed ID: 15049841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of a lipophilic captopril analogue binding to angiotensin I converting enzyme.
    Dalkas GA; Marchand D; Galleyrand JC; Martinez J; Spyroulias GA; Cordopatis P; Cavelier F
    J Pept Sci; 2010 Feb; 16(2):91-7. PubMed ID: 20014331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of vinylogous scaffolds in the C-terminal tripeptide of substance P.
    Claudel S; Tasseau O; Sagan S; Grison C; Coutrot P; Lavielle S
    J Pept Res; 2004 Nov; 64(5):186-93. PubMed ID: 15485556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a conformationally sensitive TOAC spin-labeled substance P.
    Shafer AM; Nakaie CR; Deupi X; Bennett VJ; Voss JC
    Peptides; 2008 Nov; 29(11):1919-29. PubMed ID: 18775458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of protected silaproline for a gram scale preparation.
    Martin C; Vanthuyne N; Miramon H; Martinez J; Cavelier F
    Amino Acids; 2012 Aug; 43(2):649-55. PubMed ID: 22002795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internalization of [3H]substance P analogues in NK-1 receptor transfected CHO cells.
    Sagan S; Lavielle S
    Biochem Biophys Res Commun; 2001 Apr; 282(4):958-64. PubMed ID: 11352645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational analysis of the C-terminal Gly-Leu-Met-NH2 tripeptide of substance P bound to the NK-1 receptor.
    Sagan S; Quancard J; Lequin O; Karoyan P; Chassaing G; Lavielle S
    Chem Biol; 2005 May; 12(5):555-65. PubMed ID: 15911376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogs of Substance P modified at the C-terminus which are both agonist and antagonist of the NK-1 receptor depending on the second messenger pathway.
    Sachon E; Girault-Lagrange S; Chassaing G; Lavielle S; Sagan S
    J Pept Res; 2002 May; 59(5):232-40. PubMed ID: 11966980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Backbone cyclization of the C-terminal part of substance P. Part 1: The important role of the sulphur in position 11.
    Bitan G; Zeltser I; Byk G; Halle D; Mashriki Y; Gluhov EV; Sukhotinsky I; Hanani M; Selinger Z; Gilon C
    J Pept Sci; 1996; 2(4):261-9. PubMed ID: 9231334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha,alpha'-disubstituted amino acids with silylated side chains as lipophilic building blocks for the synthesis of peptaibol analogues.
    Cavelier F; Marchand D; Martinez J
    Chem Biodivers; 2008 Jul; 5(7):1279-87. PubMed ID: 18649314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and biological effects of a beta2- or beta3-amino acid insertion in a peptide.
    Sagan S; Milcent T; Ponsinet R; Convert O; Tasseau O; Chassaing G; Lavielle S; Lequin O
    Eur J Biochem; 2003 Mar; 270(5):939-49. PubMed ID: 12603327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of silaproline on peptide conformation and bioactivity.
    Cavelier F; Vivet B; Martinez J; Aubry A; Didierjean C; Vicherat A; Marraud M
    J Am Chem Soc; 2002 Mar; 124(12):2917-23. PubMed ID: 11902882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of the peptide binding domain of the NK-1 tachykinin receptor using photoreactive analogues of substance P.
    Boyd ND; Kage R; Dumas JJ; Silberman SC; Krause JE; Leeman SE
    Ann N Y Acad Sci; 1995 May; 757():405-9. PubMed ID: 7541973
    [No Abstract]   [Full Text] [Related]  

  • 15. Calpha methylation in molecular recognition. Application to substance P and the two neurokinin-1 receptor binding sites.
    Sagan S; Lequin O; Frank F; Convert O; Ayoub M; Lavielle S; Chassaing G
    Eur J Biochem; 2001 May; 268(10):2997-3005. PubMed ID: 11358518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement of a proline with silaproline causes a 20-fold increase in the cellular uptake of a Pro-rich peptide.
    Pujals S; Fernandez-Carneado J; Kogan MJ; Martinez J; Cavelier F; Giralt E
    J Am Chem Soc; 2006 Jul; 128(26):8479-83. PubMed ID: 16802813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The two NK-1 binding sites are distinguished by one radiolabelled substance P analogue.
    Kim HR; Lavielle S; Sagan S
    Biochem Biophys Res Commun; 2003 Jul; 306(3):725-9. PubMed ID: 12810079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonists can discriminate between cloned human and mouse prostacyclin receptors.
    Chow KB; Jones RL; Wise H
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):423-9. PubMed ID: 15062844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the bioactive conformation of the C-terminal tripeptide Gly-Leu-Met-NH2 of substance P using [3-prolinoleucine10]SP analogues.
    Quancard J; Karoyan P; Sagan S; Convert O; Lavielle S; Chassaing G; Lequin O
    Eur J Biochem; 2003 Jul; 270(13):2869-78. PubMed ID: 12823557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptor.
    Perrine SA; Beard DJ; Young JK; Simmons MA
    Eur J Pharmacol; 2008 Sep; 592(1-3):1-6. PubMed ID: 18634782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.